Factors Associated with Outcome in Patients Managed for Invasive Fungal Infections at the Infectious Diseases Department of a Tertiary Care Hospital DOI Creative Commons

Fakhra Saba Zeb,

Uzma Qayyum,

Shazia Nisar

et al.

Pakistan Armed Forces Medical Journal, Journal Year: 2023, Volume and Issue: 73(2), P. 427 - 30

Published: April 18, 2023

Objective: To look for the factors associated with outcomes in patients managed invasive fungal infections at Infectious Diseases Department of a Tertiary Care Hospital Study Design: Comparative cross-sectional study Place and Duration Study: Diseases, Pak Emirates Military Hospital, Rawalpindi Pakistan,from Apr 2021 to Sep 2022. Methodology: A total 90 different types diagnosed by consultant infectious diseases were recruited. First, they given standard treatment infection; as per guidelines.Then, followed up one month an outcome. Results: Out included study, 62(68.8%) had good outcome, while 28(31.2%) poor The mean age recruited our study was 39.54±6.27 years. Of all participants, 65(72.2%) male, 25(27.8%) female. Statistical analysis revealed that poorly controlled diabetes, COVID-19 infection HIV positive statistically significantly participants (p-value<0.05). Conclusion: Considerable number outcome study. presence being participants.

Language: Английский

Invasive Aspergillosis with Cavernous Sinus Thrombosis Following High-Dose Corticosteroid Therapy: A Challenging Case of Rhino-Orbital-Cerebral Mycosis DOI Creative Commons
Faruk Karakeçili, Orçun Barkay, Betül Sümer

et al.

Journal of Fungi, Journal Year: 2024, Volume and Issue: 10(11), P. 788 - 788

Published: Nov. 13, 2024

Invasive aspergillosis is a rare but severe fungal infection primarily affecting immunocompromised individuals. The Coronavirus Disease-2019 (COVID-19) pandemic has introduced new complexities in managing due to the widespread use of corticosteroids for treating COVID-19-related respiratory distress, which can increase susceptibility infections. Here, we present challenging case progressive cerebral complicated by cavernous sinus thrombosis (CST) 67-year-old male with history COVID-19. patient, initially misdiagnosed temporal arteritis, received pulse corticosteroid therapy twice before presenting persistent left-sided headaches and vision loss. Cranial imaging revealed findings consistent sinusitis, Tolosa–Hunt syndrome, orbital pseudotumor, progressed despite initial antifungal therapy. Subsequent magnetic resonance indicated an invasive mass extending into left other intracranial structures, raising suspicion aspergillosis. A transsphenoidal biopsy confirmed Aspergillus infection, leading voriconazole Despite aggressive treatment, follow-up significant progression, extension right frontal region sinus. patient then developed visual impairment eye was diagnosed CST secondary sinusitis. Management included combination systemic antifungals antibiotics; however, declined surgical intervention. This underscores diagnostic challenges rapid progression associated post-COVID-19 patients treated corticosteroids. report highlights need heightened clinical prompt, targeted interventions similar cases improve outcomes. Further research required understand optimal management

Language: Английский

Citations

0

Perspective Chapter: Exploring Cognitive Impairment in Long COVID – Insights and Therapeutic Progress DOI Creative Commons

Chanchal Sonkar,

Shailendra Chauhan, Charu Sonkar

et al.

IntechOpen eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 4, 2024

Coronavirus disease 2019 (COVID-19) was caused by a novel severe acute respiratory syndrome related coronavirus (SARS-CoV-2) that occurred in late and soon emerged as global pandemic. Even after recovering from the initial infection, approximately 45% of patients experience persistent symptoms, known post-COVID syndromes or long COVID, which can endure for weeks to months. Among prominent lingering symptoms are fatigue, cognitive impairment (commonly referred brain fog), musculoskeletal disorders. Brain fog manifests confusion, difficulty focusing, memory loss. Although exact cause deficits induced SARS-CoV-2 remains unclear, it is speculated chronic inflammation resulting residual virus remnants body’s reservoirs stress-released peptides may play significant role. This chapter aims delve into etiology recent advancements treating associated with COVID-19, shedding light on our understanding this complex phenomenon potential therapeutic strategies.

Language: Английский

Citations

0

Scedosporiosis pulmonar post COVID-19 en paciente diabético: a propósito de un caso DOI Creative Commons
Xiomara Moreno, Carolina Macero Estévez, María Mercedes Panizo

et al.

Boletín Venezolano de Infectología, Journal Year: 2023, Volume and Issue: 33(2)

Published: Feb. 22, 2023

Las especies de Scedosporium son consideradas patógenos oportunistas emergentes, que afectan a pacientes inmunocomprometidos o con respuesta inmunológica normal. La enfermedad invasiva grave supera tasas mortalidad del 80 %. Se describe caso afectación pulmonar causada por el complejo en un paciente masculino 75 años edad, procedente Caracas, Venezuela, diabetes mellitus tipo 2, infección respiratoria baja, dos infecciones previas coronavirus 2019 (COVID-19) e imagen radiológica lesión ocupación espacio basal izquierdo. envió al laboratorio microbiología porción aproximadamente 1 cm2 tejido pulmonar, solicitando estudios micológicos y para micobacterias. Al examen directo KOH 20 % se observó fragmento hifa hialina tabicada. A los 12 días incubación hubo crecimiento agar Sabouraud dextrosa más gentamicina colonias vellosas pigmentado difusible color amarillo pálido mostaza. realizó las azul algodón, observándose estructuras compatibles Scedosporium. spp., es segundo hongo filamentoso, después Aspergillus causante respiratorias bajas. El fue tratado voriconazol diagnóstico micológico una evolución satisfactoria. órganos internos como pulmones, similar descrito. COVID-19 factor predisponente adquirir fúngicas poco frecuentes. cumple rol importante micosis causadas hongos inusuales.

Citations

0

Discovery and development of novel substituted monohydrazides as potent antifungal agents DOI
Nishad Thamban Chandrika, Keith Green,

Abbygail C. Spencer

et al.

RSC Medicinal Chemistry, Journal Year: 2023, Volume and Issue: 14(7), P. 1351 - 1361

Published: Jan. 1, 2023

Novel substituted monohydrazides synthesized for this study displayed broad-spectrum activity against various fungal strains, including a panel of clinically relevant Candida auris strains.

Language: Английский

Citations

0

Factors Associated with Outcome in Patients Managed for Invasive Fungal Infections at the Infectious Diseases Department of a Tertiary Care Hospital DOI Creative Commons

Fakhra Saba Zeb,

Uzma Qayyum,

Shazia Nisar

et al.

Pakistan Armed Forces Medical Journal, Journal Year: 2023, Volume and Issue: 73(2), P. 427 - 30

Published: April 18, 2023

Objective: To look for the factors associated with outcomes in patients managed invasive fungal infections at Infectious Diseases Department of a Tertiary Care Hospital Study Design: Comparative cross-sectional study Place and Duration Study: Diseases, Pak Emirates Military Hospital, Rawalpindi Pakistan,from Apr 2021 to Sep 2022. Methodology: A total 90 different types diagnosed by consultant infectious diseases were recruited. First, they given standard treatment infection; as per guidelines.Then, followed up one month an outcome. Results: Out included study, 62(68.8%) had good outcome, while 28(31.2%) poor The mean age recruited our study was 39.54±6.27 years. Of all participants, 65(72.2%) male, 25(27.8%) female. Statistical analysis revealed that poorly controlled diabetes, COVID-19 infection HIV positive statistically significantly participants (p-value<0.05). Conclusion: Considerable number outcome study. presence being participants.

Language: Английский

Citations

0